The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure
Anemia increases mortality in patients with chronic obstructive pulmonary disease (COPD), but its effects on mortality and survival time for different levels of airflow limitation severity are unclear. Our goal was to investigate the effects of anemia on survival time and mortality in COPD patients...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-08-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/2254 |
_version_ | 1811341235276742656 |
---|---|
author | Emel Cireli Aydan Mertoğlu |
author_facet | Emel Cireli Aydan Mertoğlu |
author_sort | Emel Cireli |
collection | DOAJ |
description |
Anemia increases mortality in patients with chronic obstructive pulmonary disease (COPD), but its effects on mortality and survival time for different levels of airflow limitation severity are unclear. Our goal was to investigate the effects of anemia on survival time and mortality in COPD patients with varying degrees of airflow limitation. We looked at 300 consecutive COPD patients in the past. Their demographic information, Charlson comorbidity index, previous early (30 days) and late (>30 days) hospitalizations, blood counts, and post-bronchodilator spirometric values were all recorded. They were contacted by phone to check on their vital status, and their mortality rates were calculated. Anemic patients had a mean overall survival time of 31.9 2.8 months and normal patients had a mean overall survival time of 41.7 2.1 months (p=0.001). Their 1-year and 2-year mortality rates are higher. Age, Charlson comorbidity index, BMI, FEV1%, anemia, MCV, hemoglobin, serum creatinin, and early and late hospitalizations all had an impact on mortality. BMI, anemia, and FEV1% remained risk factors for death. Anemic group 2 patients had a higher mortality rate than groups 3 and 4. Anemic patients in groups 2 and 4 had shorter survival times. Anemic COPD patients have higher 1-year and 2-year mortality rates. Mortality is affected by age, Charlson comorbidity index, BMI, FEV1%, anemia, MCV, hemoglobin, serum creatinin, and early and late hospitalizations. BMI, anemia, and FEV1% remained risk factors for death. Anemic group 2 patients have a higher mortality rate than groups 3 and 4. Anemic patients in groups 2 and 4 have shorter survival times.
|
first_indexed | 2024-04-13T18:53:32Z |
format | Article |
id | doaj.art-5096f7f2fb07420a968b0be2f9ec1c4c |
institution | Directory Open Access Journal |
issn | 1122-0643 2532-5264 |
language | English |
last_indexed | 2024-04-13T18:53:32Z |
publishDate | 2022-08-01 |
publisher | PAGEPress Publications |
record_format | Article |
series | Monaldi Archives for Chest Disease |
spelling | doaj.art-5096f7f2fb07420a968b0be2f9ec1c4c2022-12-22T02:34:20ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642022-08-0110.4081/monaldi.2022.2254The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failureEmel Cireli0Aydan Mertoğlu1Health Sciences University Dr. Suat Seren Chest Diseases, Chest Surgery Training and Research Hospital, IzmirHealth Sciences University Dr. Suat Seren Chest Diseases, Chest Surgery Training and Research Hospital, Izmir Anemia increases mortality in patients with chronic obstructive pulmonary disease (COPD), but its effects on mortality and survival time for different levels of airflow limitation severity are unclear. Our goal was to investigate the effects of anemia on survival time and mortality in COPD patients with varying degrees of airflow limitation. We looked at 300 consecutive COPD patients in the past. Their demographic information, Charlson comorbidity index, previous early (30 days) and late (>30 days) hospitalizations, blood counts, and post-bronchodilator spirometric values were all recorded. They were contacted by phone to check on their vital status, and their mortality rates were calculated. Anemic patients had a mean overall survival time of 31.9 2.8 months and normal patients had a mean overall survival time of 41.7 2.1 months (p=0.001). Their 1-year and 2-year mortality rates are higher. Age, Charlson comorbidity index, BMI, FEV1%, anemia, MCV, hemoglobin, serum creatinin, and early and late hospitalizations all had an impact on mortality. BMI, anemia, and FEV1% remained risk factors for death. Anemic group 2 patients had a higher mortality rate than groups 3 and 4. Anemic patients in groups 2 and 4 had shorter survival times. Anemic COPD patients have higher 1-year and 2-year mortality rates. Mortality is affected by age, Charlson comorbidity index, BMI, FEV1%, anemia, MCV, hemoglobin, serum creatinin, and early and late hospitalizations. BMI, anemia, and FEV1% remained risk factors for death. Anemic group 2 patients have a higher mortality rate than groups 3 and 4. Anemic patients in groups 2 and 4 have shorter survival times. https://www.monaldi-archives.org/index.php/macd/article/view/2254Chronic obstructivePulmonary diseaseanemiamortalitysurvival |
spellingShingle | Emel Cireli Aydan Mertoğlu The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure Monaldi Archives for Chest Disease Chronic obstructive Pulmonary disease anemia mortality survival |
title | The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure |
title_full | The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure |
title_fullStr | The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure |
title_full_unstemmed | The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure |
title_short | The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure |
title_sort | impact of anemia on the mortality of copd patients hospitalized for acute exacerbation resulting in respiratory failure |
topic | Chronic obstructive Pulmonary disease anemia mortality survival |
url | https://www.monaldi-archives.org/index.php/macd/article/view/2254 |
work_keys_str_mv | AT emelcireli theimpactofanemiaonthemortalityofcopdpatientshospitalizedforacuteexacerbationresultinginrespiratoryfailure AT aydanmertoglu theimpactofanemiaonthemortalityofcopdpatientshospitalizedforacuteexacerbationresultinginrespiratoryfailure AT emelcireli impactofanemiaonthemortalityofcopdpatientshospitalizedforacuteexacerbationresultinginrespiratoryfailure AT aydanmertoglu impactofanemiaonthemortalityofcopdpatientshospitalizedforacuteexacerbationresultinginrespiratoryfailure |